Results 121 to 130 of about 3,449 (222)

Research progress on prevention strategies for immune platelet transfusion refractoriness

Zhongguo shuxue zazhi
Platelet transfusion refractoriness (PTR) is a common issue among patients with hematological diseases and tumors. This article reviews the diagnostic criteria, influencing factors, and recent prevention and management strategies for immune PTR.
ZHAO Peizhe, XU Yi, LIANG Yajun, LI Qing, ZHOU Yuan, XU Xianguo   +5 more
doaj   +1 more source

Correlation of heavy metals and theirs impact to epidemiological survey in the miners blood donors and other human population [PDF]

, 2011
Introduction: Miners who are blood donors, and work in mines for lead-zinc ores are constantly exposed to heavy metals (lead, zinc and cadmium) and this aspect is expected to increase or decrease many hematological parameters.
Kamcev, Nikola, Kamceva, Gordana, Panov, Zoran, Velickova, Nevenka   +3 more
core  

Impact of HLA antigen and antibody expression on cross-matching and transfusion effect

Zhongguo shuxue zazhi
[Objective] To study the relationship between the expression intensity of HLA-Ⅰ platelet antibodies in patients with platelet transfusion refractoriness (PTR) and platelet cross-matching, and to further evaluate other factors in order to provide relevant
HE Honghong, CHENG Jing, WANG Yihan, JIANG Min, TANG Longhai   +4 more
doaj   +1 more source

Cytokine Release Syndrome Is an Independent Risk Factor Associated With Platelet Transfusion Refractoriness After CAR-T Therapy for Relapsed/Refractory Acute Lymphoblastic Leukemia. [PDF]

Front Pharmacol, 2021
Liu Y, Liang B, Liu Y, Wei G, Wu W, Yang L, Yang L, Huang H, Xie J, Hu Y.   +9 more
europepmc   +1 more source

A randomised controlled trial of mgso4 therapy for 24 hours versus early cessation in patients with severe preeclampsia [PDF]

, 2010
Introduction: Magnesium sulphate has been shown to be the optimal anticonvulsant in preventing the recurrence of seizures in eclampsia and in seizure prophylaxis in preeclampsia.
Yunus, Affendi
core  

Occurence and dynamics of HLA and HPA antibodies in the setting of matched related HSCT [PDF]

, 2018
Bräutigam, Michelle, Buser, Andreas, Drexler, Beatrice, Halter, Jörg, Heim, Dominik, Holbro, Andreas, Infanti, Laura, Passweg, Jakob R, Plattner, Alexandra, Volken, Thomas   +9 more
core   +1 more source

A case of platelet refractoriness in a patient with acute myelogenous leukaemia and paraplegia: management in a low resource setting [PDF]

, 2016
Background: Acute myelogenous leukaemia is a type of acute leukaemia more commonly seen in adults than in children and usually presents with features of anaemia, neutropoenia and thrombocytopoenia (pancytopoenia).
Eke, Gracia, Korubo, Kaladada Ibitrokoemi, Okoye, Helen Chioma   +2 more
core   +1 more source

Prediction model of platelet transfusion refractoriness in patients with hematological disorders

Zhongguo shuxue zazhi
Objective To explore the risk factors for platelet transfusion refractoriness(PTR)in patients with hematological disorders, construct a prediction model and validate the model efficacy.
Shuhan YUE, Xiulan HUANG, Yan ZENG, Qiao LEI, Mengzhen HE, Liqi LU, Shisong YOU, Jingwei ZHANG   +7 more
doaj   +1 more source

Platelet transfusions in cancer patients with hypoproliferative thrombocytopenia in the intensive care unit [PDF]

, 2015

core   +1 more source

Pyelolithotomy in a patient with Glanzmann thrombasthenia and antiglycoprotein IIb/IIIa antibodies: the shortest possible duration of treatment with recombinant activated factor VII and platelet transfusions

The Turkish Journal of Pediatrics, 2003
Transfusion of platelet concentrates remains the first-line therapy for Glanzmann thrombasthenia in case of bleeding or preparation for surgery. However, development of antibodies to platelet glycoprotein (Gp) IIb/IIIa complex or human leukocyte ...
Omer Devecioğlu, Ayşegül Unüvar, Sema Anak, Ilmay Bilge, Haluk Ander, Orhan Ziylan   +5 more
doaj